Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.63 |
| ▸ | LMNA | P02545 | 1/20 | 0.61 |
| ▸ | CES2 | O00748 | 2/20 | 0.42 |
| ▸ | CES1 | P23141 | 2/20 | 0.42 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.41 |
| ▸ | EGFR | P00533 | 1/20 | 0.40 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.40 |
| ▸ | TUBB4A | P04350 | 2/20 | 0.39 |
| ▸ | TUBB | P07437 | 2/20 | 0.39 |
| ▸ | TUBA3C | P0DPH7 | 2/20 | 0.39 |
| ▸ | TUBA1B | P68363 | 2/20 | 0.39 |
| ▸ | TUBA4A | P68366 | 2/20 | 0.39 |
| ▸ | TUBB4B | P68371 | 2/20 | 0.39 |
| ▸ | TUBB3 | Q13509 | 2/20 | 0.39 |
| ▸ | TUBB2A | Q13885 | 2/20 | 0.39 |
| ▸ | TUBB8 | Q3ZCM7 | 2/20 | 0.39 |
| ▸ | TUBA3E | Q6PEY2 | 2/20 | 0.39 |
| ▸ | TUBA1A | Q71U36 | 2/20 | 0.39 |
| ▸ | TUBA1C | Q9BQE3 | 2/20 | 0.39 |
| ▸ | TUBB6 | Q9BUF5 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29964257 | 1.00 | TDP1 (0.63) | TDP1LMNACES2CES1AKR1C3 | |
| SCHEMBL20424332 | 1.00 | TDP1 (0.63) | TDP1LMNACES2CES1AKR1C3 | |
| SCHEMBL20441153 | 0.99 | LMNA (0.62) | TDP1LMNACES2CES1AKR1C3 | |
| SCHEMBL20424326 | 0.89 | TDP1 (0.71) | TDP1LMNACES2CES1AKR1C3 | |
| SCHEMBL20441155 | 0.89 | TDP1 (0.67) | TDP1LMNACES2CES1AKR1C3 | |
| SCHEMBL20424345 | 0.89 | TDP1 (0.67) | TDP1LMNACES2CES1AKR1C3 | |
| SCHEMBL20424327 | 0.89 | TDP1 (0.71) | TDP1LMNACES2CES1AKR1C3 | |
| SCHEMBL20424346 | 0.89 | TDP1 (0.67) | TDP1LMNACES2CES1AKR1C3 | |
| SCHEMBL20424893 | 0.89 | TDP1 (0.71) | TDP1LMNACES2CES1AKR1C3 | |
| SCHEMBL20424898 | 0.87 | LMNA (0.66) | TDP1LMNACES2CES1AKR1C3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220378675-A1 | COMPOUNDS REDUCING MALODOUR PERCEPTION AND THE USE THEREOF | CHEMCOM S.A. (BE) | 2022-12-01 | — | — | US | disclosed |
| EP-4059917-A2 | COMPOUNDS REDUCING MALODOUR PERCEPTION AND THE USE THEREOF | ChemCom S.A. (BE) | 2022-09-21 | — | — | EP | disclosed |
| US-11382848-B2 | Compounds reducing malodour perception and the use thereof | CHEMCOM S.A. (BE) | 2022-07-12 | — | — | US | disclosed |
| US-11382848-B2 | Compounds reducing malodour perception and the use thereof | CHEMCOM S.A. (BE) | 2022-07-12 | — | — | US | disclosed |
| EP-3573944-B1 | COMPOUNDS REDUCING MALODOUR PERCEPTION AND THE USE THEREOF | CHEMCOM SA (BE) | 2022-03-02 | — | — | EP | disclosed |
| EP-3573944-B1 | COMPOUNDS REDUCING MALODOUR PERCEPTION AND THE USE THEREOF | CHEMCOM SA (BE) | 2022-03-02 | — | — | EP | disclosed |
| WO-2018138369-A1 | COMPOUNDS REDUCING MALODOUR PERCEPTION AND THE USE THEREOF | CHEMCOM S.A. (BE) | 2018-08-02 | — | — | WO | disclosed |
| WO-2018138369-A1 | COMPOUNDS REDUCING MALODOUR PERCEPTION AND THE USE THEREOF | CHEMCOM S.A. (BE) | 2018-08-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11382848-B2 | Compounds reducing malodour perception and the use thereof | OR51E2, OR10J3, SRD5A1 | TDP1 4689/4885LMNA 4749/4885CES2 2584/4885 |
| US-20220378675-A1 | COMPOUNDS REDUCING MALODOUR PERCEPTION AND THE USE THEREOF | OR51E2, OR10J3, SRD5A1 | TDP1 4689/4885LMNA 4749/4885CES2 2584/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.